Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Income Tax Expense
Income taxes recognized for the period, including current and deferred tax.
Income Tax Expense history
Currency unavailable · from the income statement
No Income Tax Expense data reported for this period type.
Income Tax Expense vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.43M USD | -18.0% | — | 0.5% | |
| LTM Mar 2026 | $160K USD | +240.4% | +89.8% | 0.1% | |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | FY2024 | €4K EUR | +100.6% | — | — |
| LTM Sep 2026 | $0 USD | +100.0% | — | 0.0% | |
ORKAOruka Therapeutics, Inc. | LTM Sep 2026 | $0 USD | — | — | — |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | — | |
ALMSAlumis Inc. Common Stock | LTM Jun 2026 | -$1.76M USD | +79.5% | — | 23.7% |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding ODTX) | — | +100.0% | +89.8% | 0.1% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.